Search results for "Dizziness"
Recommended: Move hydrocodone combo products to schedule II
This regulatory update covers a proposed reclassification of hydrocodone combination products from schedule III to schedule II, and approval of an extended-release version of hydrocodone bitartrate for pain management.
https://immattersacp.org/archives/2014/01/fda.htm
1 Jan 2014
Peanut butter recall issued, reminder for topical anesthetics
A summary of approvals, recalls, warnings and alerts.
https://immattersacp.org/archives/2009/03/fda.htm
1 Mar 2009
MKSAP Quiz: Progressive fatigue, dyspnea
A 28-year-old previously healthy woman is evaluated in the hospital for a 3-week history of progressive fatigue, dyspnea with exertion, and easy bruisability. Following a physical exam, lab studies, and peripheral blood smear, what is the most appropriate treatment?.
https://immattersacp.org/archives/2015/03/mksap.htm
1 Mar 2015
Statin treatment reduced cardiovascular events more than hypertension drugs in intermediate-risk patients, study finds
An accompanying editorial said that the results of this trial support the benefits of statins for primary prevention and a risk-based approach to prescribing, rather than one based on LDL levels.
https://immattersacp.org/weekly/archives/2016/04/05/1.htm
5 Apr 2016
FDA releases action plan on artificial intelligence software
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2021/03/fda-releases-action-plan-on-artificial-intelligence-software.htm
1 Mar 2021
Initial computed tomography angiography demonstrates equivalent clinical outcomes to functional testing in symptomatic patients with CAD
Initial testing for coronary artery disease (CAD) with computed tomography angiography (CTA) in symptomatic patients doesn't appear to yield better clinical outcomes than initial functional testing, a new study has found.
https://immattersacp.org/weekly/archives/2015/03/24/5.htm
24 Mar 2015
FDA issues alert for CellCept, recalls for Solodyn, Digitek
An overview of agency actions, including an alert for CellCept and recalls for Solodyn and Digitek.
https://immattersacp.org/archives/2008/07/fda.htm
1 Jul 2008
Analysis finds several treatments for painful diabetic neuropathy more effective than placebo
A large meta-analysis recently compared the effectiveness of pharmacological treatments for painful diabetic neuropathy.
https://immattersacp.org/weekly/archives/2014/11/04/5.htm
4 Nov 2014
Action, advocacy, partnering for falls
Partnering with patients can make a big difference in preventing falls, which can result in lingering disability.
https://immattersacp.org/archives/2018/03/action-advocacy-partnering-for-falls.htm
1 Mar 2018
For hypertension, how low to go?
Updated blood pressure guidelines may have created more questions than closure, internists have found, as they try to determine how aggressively to treat the condition and what goals to set for subpopulations of patients, such as those with diabetes. Experts react to the “paradigm shift” in lowering hypertension.
https://immattersacp.org/archives/2014/04/hypertension.htm
1 Apr 2014